Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-23-014514

Chief Financial Officer acquired 3,302 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2023-06-01 Grant or award +1,651 $22.97 $37,923 5,757 D
Mokari Atabak Chief Financial Officer 2023-06-01 Grant or award +1,651 7,408 D
Loading xslF345X04/doc4.xml…